Project Details
| Status | Active |
|---|---|
| Effective start/end date | 2/08/26 → 1/08/31 |
Clinical Trial Phase
- Phase III (a & b)
A Phase III, Randomised, Open-label, Sponsor-blinded, Multicentre Study of Rilvegostomig in Combination with Bevacizumab with or without Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma (ARTEMIDE-HCC01)
- Dev, Anouk (Primary Chief Investigator (PCI))
Project: Research